AstraZeneca executive vice president dies of rare disease

Pharmaceutical company AstraZeneca, one of the developers of the coronavirus vaccine, has announced the death of executive vice president Jose Baselga. The statement did not specify a cause, but according to Spanish media reports, the oncologist was suffering from Creutzfeldt-Jakob disease, a rare rapidly developing degenerative neurological disorder.

– We are deeply saddened by the news that Jose Baselga, executive vice president of oncology research and development and a member of our senior executive team, has passed away,” AstraZeneca CEO Pascal Sorio said in a statement.

Barcelona-born José Baselga was 61 years old. AstraZeneca is an Anglo-Swedish biopharmaceutical company engaged in drug discovery, development and commercialization. It began developing a vaccine against coronavirus in 2020 together with scientists from Oxford. At the end of February 2021, the Covishield vaccine, an analogue of AstraZeneca’s drug produced in India, was brought to Ukraine. In March, several European countries suspended vaccination with AstraZeneca due to reports of thrombosis, but the WHO found no direct link with the drug.